NCCN Guidelines® Updates: Gastric and Esophageal Cancers
Decisions regarding treatment for advanced or metastatic gastroesophageal cancers require that clinicians be familiar with new and existing chemotherapy agents and targeted therapies as well as the current evidence regarding the survival rates and toxicities associated with various treatment approaches.
  • Gastric/Esophageal Cancer
  • Recorded Webcast
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation